ERBB2 and non-small cell lung carcinoma: The gene for ErbB2 is amplified or overexpressed in approximately 30% of breast cancer carcinomas and in many other malignancies, including ovarian cancer, gastric cancer, bladder carcinoma, and non-small cell lung cancer (NSCLC).